Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

We have studied the efficacy and the prognostic impact of novel agents in 50 primary plasma cell leukemia (pPCL) patients registered in our database. Eighty percent of patients were treated upfront with novel agent-based combinations; 40% underwent autologous stem cell transplantation (ASCT). Object...

Descripción completa

Detalles Bibliográficos
Autores principales: Katodritou, Eirini, Terpos, Evangelos, Delimpasi, Sossana, Kotsopoulou, Maria, Michalis, Eurydiki, Vadikolia, Chrysanthi, Kyrtsonis, Marie-Christine, Symeonidis, Argiris, Giannakoulas, Nikolaos, Vadikolia, Chrissa, Michael, Michalis, Kalpadakis, Christina, Gougopoulou, Theodora, Prokopiou, Chrystalla, Kaiafa, Georgia, Christoulas, Dimitrios, Gavriatopoulou, Maria, Giannopoulou, Evlampia, Labropoulou, Vasiliki, Verrou, Evgenia, Kastritis, Efstathios, Konstantinidou, Pavlina, Anagnostopoulos, Achilles, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849880/
https://www.ncbi.nlm.nih.gov/pubmed/29523783
http://dx.doi.org/10.1038/s41408-018-0059-6

Ejemplares similares

Ejemplares similares